Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling.
Prediction of disease severity in neuromyelitis optica by the levels of IL-6 produced during remission phase.
Monitoring technology for wheelchair users with advanced multiple sclerosis.
Primary CNS lymphoma masquerading as tumefactive demyelination.
Leber hereditary optic neuropathy and multiple sclerosis: the mitochondrial connection.
Handling changes in MRI acquisition parameters in modeling whole brain lesion volume and atrophy data in multiple sclerosis subjects: Comparison of linear mixed-effect models.
Treatment satisfaction and improvement in health-related quality of life with onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity.
Human Herpesvirus 6A Partially Suppresses Functional Properties of DC without Viral Replication.
Magnetic resonance imaging characterization of different experimental autoimmune encephalomyelitis models and the therapeutic effect of glatiramer acetate.
P wave duration and dispersion and QT interval in multiple sclerosis.
The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors.
JNK inhibitors as anti-inflammatory and neuroprotective agents.
Medication use in a large international sample of people with multiple sclerosis: associations with quality of life, relapse rate and disability.
Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.
Secondary progressive multiple sclerosis: a shared therapeutic decision.
Novel MRI and PET markers of neuroinflammation in multiple sclerosis.
EBV-Associated Cancer and Autoimmunity: Searching for Therapies.
Tumefactive demyelination following herbal supplement use: Cause or coincidence?
Quality of life among people with multiple sclerosis: Replication of a three-factor prediction model.
Dysfunction of neuronal calcium signalling in neuroinflammation and neurodegeneration.
Autoimmune T-Cell Reactivity to Myelin Proteolipids and Glycolipids in Multiple Sclerosis.
Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls.
Complement C1q-C3 associated synaptic changes in multiple sclerosis hippocampus.
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.
Pages
« first
‹ previous
…
389
390
391
392
393
394
395
396
397
…
next ›
last »